NLRP3 and Parkinson disease: Altogether, our data demonstrates that SARS-CoV-2, and spike protein, can both prime and activate the NLRP3 inflammasome in human microglia, also potentiating activation in the presence of α-synuclein, supporting a possible risk factor for COVID-19 in Parkinson’s disease and neurodegeneration.